Endogenous Protein‐Modified Gold Nanorods as Immune‐Inert Biomodulators for Tumor‐Specific Imaging and Therapy
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404548 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chunyan Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Institute of Translational Medicine, Shanghai Ji…. Hauptthemen laut MEDLINE: Gold, Nanotubes, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, Interdisciplinary Program of Shanghai Jiao Tong University, Anhui Sharp Talent Cultivation Funding Program.
Abstract (Originalsprache)
Engineered modifications of nanomaterials inspired by nature hold great promise for disease‐specific imaging and therapies. However, conventional polyethylene glycol modification is limited by immune system rejection. The manipulation of gold nanorods (Au NRs) modified by endogenous proteins (eP@Au) is reported as an engineered biomodulator for enhanced breast tumor therapy. The results show that eP@Au NRs neither activate inflammatory factors in vitro nor elicit rejection of immune responses in vivo. Tumor‐specific eP@Au NRs exhibit a dual‐modal imaging capability and trigger a mild photothermal effect under near‐infrared light irradiation, enabling highly efficient imaging and therapy of tumors. Transcriptome sequencing and confirmatory experiments reveal that the antitumor effect is mainly attributed to the repression of PI3K‐Akt/MAPK signaling pathways at the molecular level. This powerful and surprising in situ eP‐regulated biomodulation demonstrates the advantages of convenient fabrication, inert immunogenicity, and biocompatibility, providing an alternative strategy for biomedical imaging and therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
- Department of Basic Medicine, Shanxi Medical University, Jinzhong, 030000, P.R. China.
- Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, 200240, P.R. China.
- School of Laboratory Medicine, Wannan Medical College, Wuhu, 241002, P.R. China.
ORCID-Profile: Chunyan Fang
Förderung
- National Key Research and Development Program of China
- Interdisciplinary Program of Shanghai Jiao Tong University
- Anhui Sharp Talent Cultivation Funding Program
- Key Projects of Scientific Research Fund of Wannan Medical College
Zitieren
APA
Fang, C., Cai, Y., He, C., Li, Y., He, L., Wang, X., & Lu, Y. (2025). Endogenous Protein‐Modified Gold Nanorods as Immune‐Inert Biomodulators for Tumor‐Specific Imaging and Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404548
Vancouver
Fang C, Cai Y, He C, Li Y, He L, Wang X, et al. Endogenous Protein‐Modified Gold Nanorods as Immune‐Inert Biomodulators for Tumor‐Specific Imaging and Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404548
BibTeX
@article{Fang2025,
author = {Fang, Chunyan and Cai, Yueming and He, Cui and Li, Ying and He, Lei and Wang, Xiaoyan and Lu, Yong},
title = {Endogenous Protein‐Modified Gold Nanorods as Immune‐Inert Biomodulators for Tumor‐Specific Imaging and Therapy},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404548}
}
EUVIMED